PTX-100

DB18125InvestigationalSmall molecule

PTX-100: Overview.

Chemical structure of PTX-100
Formula / weight
C23H31N5O4 · 441.532 g/mol (avg)
Also known as
2-{[2-benzyl-4-(5-methyl-3H-imidazol-4-ylmethyl)-3-oxo-piperazine-1-carbonyl]- amino}-4methyl-pentanoic acid
Code names
GGTI-2418 · PTX-100

Resolves to

Compound
UNIIM67G28K74KCAS501010-06-6ChEMBLCHEMBL3218390
Structure
InChIKeyCOLCNDRDBCLVOC-ICSRJNTNSA-NSMILESCC(C)C[C@H](NC(=O)N1CCN(CC2=C(C)N=CN2)C(=O)[C@@H]1CC1=CC=CC=C1)C(O)=O
Targets
P49356FNTBP49354FNTA

What you can answer from here — as of April 23, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PTX-100, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In